The Consensus Standards and Approval Committee (CSAC) recently reviewed measures submitted to the following projects for the Spring 2023 E&M cycle:
During its meeting on December 6, the CSAC discussed and made final endorsement decisions on three measures. The committee also reviewed and rendered decisions on an additional nine measures using a consent calendar, a separate online voting process. In total, the CSAC endorsed nine measures, approved one electronic clinical quality measure for trial use, and did not endorse two measures. View the final endorsement decisions on the CSAC webpage.
Submit an Appeal
The 30-day appeals period for endorsed measures only is open through 11:59 p.m. (ET) January 9, 2024. Appeals may be filed on the following grounds:
- Procedural errors reasonably likely to affect the outcome of the original endorsement decision, such as a failure to follow the E&M process; or
- New information or evidence, unavailable at the time the CSAC made its endorsement decision, that is reasonably likely to affect the outcome of the original endorsement decision.
Submit an appeal request to [email protected] with the subject line “Appeal Request for CBE #XXXX.” If an appeal is eligible, the Appeals Board will be convened.
Please email [email protected] if you have any questions.